[{"edinetCode":"E21183","endDate":"2016\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":31787.0,"averageTemporaryStaff":4653.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":216668000.0,"sharesOwendPercent":0.3883,"outstandingShares":null,"numberOfSubsidiary":null,"bps":3023.09,"equityRatio":0.679,"cashAndCashEquivalents":369789000000.0,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":30125000000.0,"eps":158.32,"dilutedEps":158.24,"dividendPerShare":null,"per":32.2,"roe":0.052,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/3\/31","stockCode":4578,"accountingYear":"第９期（自　2016年１月１日　至　2016年12月31日）","accountingYearStart":"2016\/1\/1","accountingYearEnd":"2016\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":32817.0,"averageTemporaryStaff":4367.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":242873000.0,"sharesOwendPercent":0.4354,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":23.8,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/3\/30","stockCode":4578,"accountingYear":"第10期（自　2017年１月１日　至　2017年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":32935.0,"averageTemporaryStaff":4063.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":241337000.0,"sharesOwendPercent":0.4454,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":29.5,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/3\/29","stockCode":4578,"accountingYear":"第11期（自　2018年１月１日　至　2018年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/14","stockCode":4578,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":239016000.0,"sharesOwendPercent":0.4408,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/8\/9","stockCode":4578,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/13","stockCode":4578,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":32992.0,"averageTemporaryStaff":4845.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":231353000.0,"sharesOwendPercent":0.4266,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2581310000000.0,"currentAssets":988351000000.0,"fixedAsset":null,"tangibleFixedAssets":453380000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":785869000000.0,"currentLiabilities":440891000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":505520000000.0,"accumulatedEarnings":1304570000000.0,"treasuryStock":-46018000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":451297000000.0,"grossProfit":null,"sgaExpenses":557607000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":20.8,"roe":null,"cashFlowFromOperatingActivities":192634000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-52279000000.0,"cashFlowFromFinancialActivities":-89267000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2020\/3\/30","stockCode":4578,"accountingYear":"第12期（自　2019年１月１日　至　2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2532160000000.0,"currentAssets":950466000000.0,"fixedAsset":null,"tangibleFixedAssets":447111000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":760039000000.0,"currentLiabilities":421201000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506079000000.0,"accumulatedEarnings":1314630000000.0,"treasuryStock":-46018000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":105325000000.0,"grossProfit":null,"sgaExpenses":133700000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":72372000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-34234000000.0,"cashFlowFromFinancialActivities":-38519000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/5\/28","stockCode":4578,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":234180000.0,"sharesOwendPercent":0.4318,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2581220000000.0,"currentAssets":971310000000.0,"fixedAsset":null,"tangibleFixedAssets":447135000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":746014000000.0,"currentLiabilities":415524000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506002000000.0,"accumulatedEarnings":1363650000000.0,"treasuryStock":-45780000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":215545000000.0,"grossProfit":null,"sgaExpenses":266387000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":118374000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-60232000000.0,"cashFlowFromFinancialActivities":-54019000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2020\/8\/11","stockCode":4578,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2582930000000.0,"currentAssets":968463000000.0,"fixedAsset":null,"tangibleFixedAssets":456219000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":727976000000.0,"currentLiabilities":395700000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506145000000.0,"accumulatedEarnings":1377590000000.0,"treasuryStock":-45780000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":328511000000.0,"grossProfit":null,"sgaExpenses":404981000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":187991000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-86688000000.0,"cashFlowFromFinancialActivities":-91089000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/11\/13","stockCode":4578,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":33151.0,"averageTemporaryStaff":5069.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":207650000.0,"sharesOwendPercent":0.3829,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2627810000000.0,"currentAssets":1003730000000.0,"fixedAsset":null,"tangibleFixedAssets":462131000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":744374000000.0,"currentLiabilities":416213000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506295000000.0,"accumulatedEarnings":1402640000000.0,"treasuryStock":-45781000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":439749000000.0,"grossProfit":null,"sgaExpenses":562434000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":16.2,"roe":null,"cashFlowFromOperatingActivities":232839000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-99863000000.0,"cashFlowFromFinancialActivities":-104932000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2021\/3\/31","stockCode":4578,"accountingYear":"第13期（自　2020年１月１日　至　2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2699830000000.0,"currentAssets":1014750000000.0,"fixedAsset":null,"tangibleFixedAssets":469505000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":742340000000.0,"currentLiabilities":416423000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506457000000.0,"accumulatedEarnings":1421900000000.0,"treasuryStock":-45781000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":109972000000.0,"grossProfit":null,"sgaExpenses":134220000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":73197000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-8810000000.0,"cashFlowFromFinancialActivities":-34780000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/5\/14","stockCode":4578,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":208351000.0,"sharesOwendPercent":0.3841,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2732180000000.0,"currentAssets":1050330000000.0,"fixedAsset":null,"tangibleFixedAssets":471476000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":732632000000.0,"currentLiabilities":417942000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506428000000.0,"accumulatedEarnings":1468730000000.0,"treasuryStock":-45571000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":235207000000.0,"grossProfit":null,"sgaExpenses":283052000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":127938000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-19437000000.0,"cashFlowFromFinancialActivities":-48721000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2021\/8\/6","stockCode":4578,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E21183","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":2815770000000.0,"currentAssets":1064060000000.0,"fixedAsset":null,"tangibleFixedAssets":483116000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":798158000000.0,"currentLiabilities":484677000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":81690000000.0,"capitalSurplus":506574000000.0,"accumulatedEarnings":1478400000000.0,"treasuryStock":-45571000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":358668000000.0,"grossProfit":null,"sgaExpenses":439009000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":197210000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-33009000000.0,"cashFlowFromFinancialActivities":-83724000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/11\/12","stockCode":4578,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E21183","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":81690,"settlementDate":"2022\/12\/31","submitterName":"大塚ホールディングス株式会社","submitterNameEnglish":"Otsuka Holdings Co., Ltd.","submitterNameKana":"オオツカホールディングスカブシキカイシャ","location":"千代田区神田司町２－９","industory":"医薬品","corporateNumber":4010000000000.0}]